Tag Archives: Mcl-1

European pharmaceutical company Servier partners with Walter and Eliza Hall Institute to develop new agents that could be effective in treating several types of cancer

Melbourne, Australia and Suresnes, France, 2-10-2014 — /EuropaWire/ — The European pharmaceutical company Servier has established a collaborative partnership with the Walter and Eliza Hall Institute to facilitate the development of new agents that could be effective in treating several types of … Read the full press release